Crowne Point Endoscopy and Surgery Center 6240 Rashelle Dr 37,171 SF 84% Leased Office Building Flint, MI 48507 $11,798,070 CAD ($317.40 CAD/SF) 7.56% Cap Rate

Jennifer Stein Real Estate, Inc, LLC is proud to present the exclusive opportunity to acquire 6240 Rashelle Drive, a 31,780-square-foot, purpose-built medical facility anchored by Blue Cloud Pediatric Surgery Centers, a rapidly expanding national ambulatory surgery platform. The property is located in Flint, Michigan, serving Genesee County and the surrounding region, with access to major hospital systems, specialty physician practices, and sustained outpatient procedure demand. This institutional-grade asset provides investors with durable cash flow secured by a long term triple-net lease, minimal landlord obligations, and exposure to one of the most resilient segments of healthcare real estate.
The first floor is solely occupied by Blue Cloud Pediatric Surgery Centers, which operates the on-site ambulatory surgery center. The ASC features multiple procedure rooms, dedicated pre- and post-operative recovery areas, and clinical infrastructure constructed to modern surgical center standards. In 2024, Blue Cloud assumed long-term operations of the Center as part of a strategic regional expansion initiative, underscoring the facility’s mission-critical importance, referral stability, and sustained case volume demand.
In addition to the anchor tenancy, the property is leased to a complementary mix of established physician practices, further diversifying income while maintaining a healthcare-only tenant profile. The rent roll is NNN with annual escalations, and in-place rents remain below current market levels, offering meaningful upside.
Positioned in a densely populated and medically active region serving Genesee County and the surrounding markets, 6240 Rashelle Drive benefits from proximity to leading hospital systems, strong physician referral networks, and sustained outpatient demand. The combination of long-term ASC tenancy, institutional-quality construction, limited competitive supply, and defensive healthcare fundamentals positions the asset as a core-plus medical investment offering long-term income stability, downside protection, and meaningful value preservation.